- |||||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono
Trial completion, Enrollment change: Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Dec 12, 2014 P3, N=24, Completed, Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Oct 2014 | Trial primary completion date: Nov 2016 --> Apr 2015 Recruiting --> Completed | N=75 --> 24
- |||||||||| clindamycin phosphate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: TUPAC: Treatment Utility of Postpartum Antibiotics in Chorioamnionitis (clinicaltrials.gov) - Dec 10, 2014 P4, N=80, Terminated, Trial primary completion date: Oct 2014 --> Jul 2015 N=238 --> 80 | Recruiting --> Terminated | Trial primary completion date: Jul 2013 --> Jul 2014; Futility in patient enrollment
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: FAST-L: Fibroid Ablation Study - Large Fibroids (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=6, Terminated, N=50 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Jun 2014; Investigational device changes N=48 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Investigational device changes
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: FAST-EU: Fibroid Ablation Study (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=51, Terminated, N=48 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Investigational device changes N=100 --> 51 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Mar 2014; Investigational device changes; adequate enrollment achieved
- |||||||||| Truseltiq (infigratinib) / BridgeBio, Pfizer, Helsinn, Xediton Pharma
New P1 trial, Combination therapy, Metastases: Ph Ib/BGJ398/Cervix and Other Solid Tumors (clinicaltrials.gov) - Dec 10, 2014 P1, N=24, Not yet recruiting,
- |||||||||| Trial completion, Trial primary completion date: Risk Assessment of Long-Haul Truck Drivers (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=294, Completed, N=100 --> 51 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Mar 2014; Investigational device changes; adequate enrollment achieved Recruiting --> Completed | Trial primary completion date: Aug 2010 --> Mar 2010
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: X-Chromosome Inactivation Status and Premature Ovarian Failure (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=13, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | N=40 --> 13 | Trial primary completion date: Nov 2008 --> Oct 2009
- |||||||||| metformin / Generic mfg.
Phase classification: Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) (clinicaltrials.gov) - Dec 6, 2014 P1/2, N=150, Recruiting, N=20 --> 115 | Recruiting --> Terminated | Trial primary completion date: Apr 2009 --> Oct 2012; Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by other system Phase classification: P1 --> P1/2
- |||||||||| Jevtana (cabazitaxel) / Sanofi, Emcure
Enrollment change, Trial termination, Trial primary completion date: Cabazitaxel in Platinum Refractory Ovarian Cancer (clinicaltrials.gov) - Dec 5, 2014 P2, N=4, Terminated, N=40 --> 4 | Recruiting --> Terminated | Trial primary completion date: Jul 2015 --> Jul 2014; Too low inclusion rate. Only 4 patients included over 16 months
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Improving Knowledge About Infertility; an Online Educational Tool (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=72, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed | N=100 --> 72 | Trial primary completion date: Oct 2013 --> Sep 2014
- |||||||||| Trial completion, Enrollment change: Effects of Early Abuse on Adult Intimate Relationships (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=148, Completed, Not yet recruiting --> Completed | N=100 --> 72 | Trial primary completion date: Oct 2013 --> Sep 2014 Active, not recruiting --> Completed | N=300 --> 148
- |||||||||| Elonva (corifollitropin alfa) / Organon
Trial completion, Enrollment change, Trial primary completion date: D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists (clinicaltrials.gov) - Dec 5, 2014 P4, N=67, Completed, Active, not recruiting --> Completed | N=300 --> 148 Recruiting --> Completed | N=50 --> 67 | Trial primary completion date: Dec 2012 --> Mar 2013
|